KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Share-based Compensation (2017 - 2026)

Johnson & Johnson's Share-based Compensation history spans 18 years, with the latest figure at $300.0 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 4.17% to $300.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.4 billion, a 17.56% increase, with the full-year FY2025 number at $1.4 billion, up 15.14% from a year prior.
  • Share-based Compensation hit $300.0 million in Q1 2026 for Johnson & Johnson, down from $309.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for JNJ hit a ceiling of $410.0 million in Q2 2025 and a floor of $178.0 million in Q4 2023.
  • Historically, Share-based Compensation has averaged $299.2 million across 5 years, with a median of $300.0 million in 2026.
  • Biggest five-year swings in Share-based Compensation: decreased 18.35% in 2023 and later skyrocketed 33.71% in 2024.
  • Tracing JNJ's Share-based Compensation over 5 years: stood at $278.0 million in 2022, then crashed by 35.97% to $178.0 million in 2023, then surged by 33.71% to $238.0 million in 2024, then rose by 29.83% to $309.0 million in 2025, then dropped by 2.91% to $300.0 million in 2026.
  • Business Quant data shows Share-based Compensation for JNJ at $300.0 million in Q1 2026, $309.0 million in Q4 2025, and $347.0 million in Q3 2025.